Observational Study of Postoperative Treatment in the Cases of Complete Excision for Non-Small-Cell Lung Cancer of Pathological Stage I (T1>2 cm, TNM Classification Version 6)
Not Applicable
- Conditions
- Advanced lung cancer
- Registration Number
- JPRN-UMIN000015732
- Lead Sponsor
- C-03 Executive committee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- o longer recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Among the patients with non-small-cell lung cancer which has been completely excised by surgical lung lobectomy or more extensive surgical resection and lymph node dissection/selective lymph node dissection of at least ND2a, and has been diagnosed as Pathological Stage I (T1>2 cm, TNM classification, Version 6) during the period from the starting month at each site, as defined elsewhere, to December 31, 2013, those who have not been enrolled in the clinical study of postoperative treatment will be selected as the subjects.
Exclusion Criteria
No
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Study A<br>Reasons why the subjects have not been enrolled in the clinical study and the percentages<br><br>Study B<br>Overall survival
- Secondary Outcome Measures
Name Time Method Study A<br>?Patient backgrounds<br>?Treatment implementation rate, contents of treatment, adherence <br>?Overall survival time <br>?Disease specific survival<br>?Correlations among above endpoints<br><br>Study B<br>?Disease specific survival<br>?Patient backgrounds<br>?Treatment implementation rate, adherence<br>?Correlations among above endpoints